
==== Front
Crit Care
Critical Care
1364-8535
1466-609X
BioMed Central London

5082
10.1186/s13054-024-05082-z
Guideline
Neurological monitoring and management for adult extracorporeal membrane oxygenation patients: Extracorporeal Life Support Organization consensus guidelines
Cho Sung-Min csungmi1@jhmi.edu

12
Hwang Jaeho 1
Chiarini Giovanni 34
Amer Marwa 56
Antonini Marta V. 7
Barrett Nicholas 8
Belohlavek Jan 9
Brodie Daniel 10
Dalton Heidi J. 11
Diaz Rodrigo 12
Elhazmi Alyaa 56
Tahsili-Fahadan Pouya 113
Fanning Jonathon 14
Fraser John 14
Hoskote Aparna 15
Jung Jae-Seung 16
Lotz Christopher 17
MacLaren Graeme 18
Peek Giles 19
Polito Angelo 20
Pudil Jan 9
Raman Lakshmi 21
Ramanathan Kollengode 18
Dos Reis Miranda Dinis 22
Rob Daniel 9
Salazar Rojas Leonardo 23
Taccone Fabio Silvio 24
Whitman Glenn 2
Zaaqoq Akram M. 25
Lorusso Roberto 3
1 grid.21107.35 0000 0001 2171 9311 Divisions of Neuroscience Critical Care and Cardiac Surgery Departments of Neurology, Neurosurgery, and Anaesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Phipps 455, Baltimore, MD 21287 USA
2 grid.21107.35 0000 0001 2171 9311 Division of Cardiac Surgery, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD USA
3 https://ror.org/02d9ce178 grid.412966.e 0000 0004 0480 1382 Cardiothoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands
4 grid.412725.7 Division of Anaesthesiology, Intensive Care and Emergency Medicine, Spedali Civili University, Affiliated Hospital of Brescia, Brescia, Italy
5 https://ror.org/05n0wgt02 grid.415310.2 0000 0001 2191 4301 Medical/Critical Pharmacy Division, King Faisal Specialist Hospital and Research Center, 11564 Al Mathar Ash Shamali, Riyadh, Saudi Arabia
6 https://ror.org/00cdrtq48 grid.411335.1 0000 0004 1758 7207 Alfaisal University College of Medicine, Riyadh, Saudi Arabia
7 grid.414682.d 0000 0004 1758 8744 Bufalini Hospital, AUSL della Romagna, Cesena, Italy
8 grid.420545.2 0000 0004 0489 3985 Department of Critical Care Medicine, Guy’s and St Thomas’ National Health Service Foundation Trust, London, UK
9 https://ror.org/024d6js02 grid.4491.8 0000 0004 1937 116X 2nd Department of Medicine, Cardiology and Angiologiy, General University Hospital and 1st School of Medicine, Charles University, Prague, Czech Republic
10 grid.21107.35 0000 0001 2171 9311 Division of Pulmonary, and Critical Care Medicine, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD USA
11 https://ror.org/05wf30g94 grid.254748.8 0000 0004 1936 8876 Departments of Surgery and Pediatrics, Creighton University, Omaha, NE USA
12 grid.413361.2 Programa de Oxigenación Por Membrana Extracorpórea, Hospital San Juan de Dios Santiago, Santiago, Chile
13 grid.417781.c 0000 0000 9825 3727 Medical Critical Care Service, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, VA USA
14 https://ror.org/02cetwy62 grid.415184.d 0000 0004 0614 0266 Critical Care Research Group, Adult Intensive Care Services, The Prince Charles Hospital and University of Queensland, Rode Rd, Chermside, QLD 4032 Australia
15 https://ror.org/00zn2c847 grid.420468.c Cardiorespiratory and Critical Care Division, Great Ormond Street Hospital for, Children National Health Service Foundation Trust, London, UK
16 https://ror.org/047dqcg40 grid.222754.4 0000 0001 0840 2678 Department of Thoracic and Cardiovascular Surgery, Korea University Medicine, Seoul, Republic of Korea
17 https://ror.org/03pvr2g57 grid.411760.5 0000 0001 1378 7891 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, Würzburg, Germany
18 https://ror.org/05tjjsh18 grid.410759.e 0000 0004 0451 6143 Cardiothoracic Intensive Care Unit, Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore, Singapore
19 https://ror.org/02y3ad647 grid.15276.37 0000 0004 1936 8091 Congenital Heart Center, Departments of Surgery and Pediatrics, University of Florida, Gainesville, FL USA
20 grid.150338.c 0000 0001 0721 9812 Pediatric Intensive Care Unit, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospital, Geneva, Switzerland
21 https://ror.org/05byvp690 grid.267313.2 0000 0000 9482 7121 Department of Pediatrics, Section Critical Care Medicine, Children’s Medical Center at Dallas, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX USA
22 https://ror.org/018906e22 grid.5645.2 0000 0004 0459 992X Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands
23 https://ror.org/00q67qp92 grid.418078.2 0000 0004 1764 0020 ECMO Department, Fundacion Cardiovascular de Colombia, Floridablanca, Santander, Colombia
24 https://ror.org/01r9htc13 grid.4989.c 0000 0001 2348 6355 Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium
25 https://ror.org/0153tk833 grid.27755.32 0000 0000 9136 933X Department of Anesthesiology, Division of Critical Care, University of Virginia, Charlottesville, VA USA
6 9 2024
6 9 2024
2024
28 29617 7 2024
28 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Background

Critical care of patients on extracorporeal membrane oxygenation (ECMO) with acute brain injury (ABI) is notable for a lack of high-quality clinical evidence. Here, we offer guidelines for neurological care (neurological monitoring and management) of adults during and after ECMO support.

Methods

These guidelines are based on clinical practice consensus recommendations and scientific statements. We convened an international multidisciplinary consensus panel including 30 clinician-scientists with expertise in ECMO from all chapters of the Extracorporeal Life Support Organization (ELSO). We used a modified Delphi process with three rounds of voting and asked panelists to assess the recommendation levels.

Results

We identified five key clinical areas needing guidance: (1) neurological monitoring, (2) post-cannulation early physiological targets and ABI, (3) neurological therapy including medical and surgical intervention, (4) neurological prognostication, and (5) neurological follow-up and outcomes. The consensus produced 30 statements and recommendations regarding key clinical areas. We identified several knowledge gaps to shape future research efforts.

Conclusions

The impact of ABI on morbidity and mortality in ECMO patients is significant. Particularly, early detection and timely intervention are crucial for improving outcomes. These consensus recommendations and scientific statements serve to guide the neurological monitoring and prevention of ABI, and management strategy of ECMO-associated ABI.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13054-024-05082-z.

Keywords

ECMO
Guidelines
Neuromonitoring
Neurological care
ICU care
Acute brain injury
Stroke
Neurological outcomes
NIH1K23HL157610 Cho Sung-Min issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Extracorporeal membrane oxygenation (ECMO) is increasingly utilized, yet patients receiving ECMO support commonly experience major complications, including acute brain injury (ABI). ABI increases in-hospital mortality by a factor of 2–3 [1, 2]. ABI is more common in venoarterial (VA) ECMO than venovenous (VV) ECMO, especially for those with extracorporeal cardiopulmonary resuscitation (ECPR) with 27–32% of ABI during ECMO support (Table 1) despite its survival benefit [3, 4]. Although a protocolized neurological monitoring is shown to improve the detection of ABI, this is limited to a few ECMO centers [5]. The management of ECMO patients in the intensive care unit (ICU) is not standardized, and neurological monitoring and care vary significantly across ECMO centers, thus, the ICU management of patients with ABI during ECMO lacks high-quality evidence and recommendations.Table 1 Different ABI types and their weighted prevalence during ECMO support (meta-analysis) [6]

Types	Frequency	ECMO configuration	
All ABI types	16% (95% CI 13–19%)	VA ECMO (19%); VV ECMO (10%)	
Hypoxic-ischemic brain injury	8% (95% CI 3–14%)	VA ECMO (13%); VV ECMO (1%)	
Ischemic stroke	7% (95% CI 4–9%)	VA ECMO (10%); VV ECMO (1%)	
Intracerebral hemorrhage	7% (95% CI 5–9%)	VA ECMO ECMO (6%); VV ECMO (8%)	
Subarachnoid hemorrhage	4% (95% CI 1–9%)	VA ECMO ECMO (11%)*; VV ECMO ECMO (4%)	
ABI = acute brain injury, ECMO = extracorporeal membrane oxygenation, VA = venoarterial, VV = venovenous.

*Reported in only one cohort study.

As clinical experience accumulates and ECMO becomes more widely used, clinical guidelines and focused research on neurological monitoring and management of ABI are imperative to enhance ECMO patient care and improve early as well as long-term outcomes. This heterogeneity presents an opportunity to standardize and facilitate neurological care in ECMO [5].

To establish clinical guidelines on this topic, an international multidisciplinary panel of experts specialized in neurology, critical care, surgery, and other ECMO-related fields was assembled to provide clinical practice consensus recommendations and scientific statements in neurological monitoring and management of adult ECMO patients. These recommendations and statements have been promoted and endorsed by the Extracorporeal Life Support Organization (ELSO). We identified five key clinical areas needing recommendations: (1) neurological monitoring, (2) post-cannulation early physiological targets and their associations with ABI, (3) neurological therapy including medical and surgical intervention, (4) neurological prognostication, and (5) neurological follow-up and outcomes. Here, we present consensus recommendations based on the available evidence and related knowledge gaps warranting further investigations were also identified and summarized (Table 2).Table 2 Key gaps in knowledge and future direction for neurological care of ECMO

Prevention and early recognition of acute brain injury in ECMO patients	
Universally agreed-upon protocol for the neuromonitoring of ECMO patients	
Optimum analgo-sedative medication uses and pharmacokinetics when the patient is on ECMO	
The impact of hyperoxemia (PaO2 > 300 mmHg) on the development of acute brain injury in ECMO patients	
The change in PaCO2, specifically in VA ECMO patients, and the development of acute brain injury	
The utilization of hypothermia and the optimal temperature target on postcardiac arrest patients supported by ECPR	
The blood pressure goal to maintain cerebral perfusion/autoregulation to prevent acute brain injury	
Interventional neurology and neurosurgery	
Standardized approach for managing neurological complications for patients supported by ECMO	
Safety of using tPA in patients on ECMO

The optimum anticoagulation goal to prevent acute brain injury on ECMO

	
The safe duration of holding anticoagulation for patients with intracranial hemorrhage and support by VA ECMO	
Neurological prognostication	
The decision on the duration of ECMO support when there is a lack of neurological recovery	
Long-term outcomes and quality of life	
The natural progression of acute brain injury in patients supported by ECMO	
The utility of brain imaging findings on patient management and subsequent outcomes	
The long-term cognitive and psychological outcomes for patients supported by ECMO	
The long-term impact on the society and the caregivers

Quality of life for patients with acute brain injury supported by ECMO

	
ECMO: extracorporeal membrane oxygenation, PaCO2: partial pressure of carbon dioxide; PaO2: partial pressure of oxygen; tPA: tissue plasminogen activator; VA: venoarterial.

Methods

Consensus guideline members

ELSO, an international non-profit consortium of healthcare institutions, researchers, and industry partners, developed this consensus statement. ELSO consists of 611 ECMO centers, with chapters in Europe, Asia–Pacific, North America, Latin America, Southwest Asia, and Africa.

An international multidisciplinary consensus panel of 30 experts, including neurologists, intensivists, surgeons, perfusionists, and other professionals in intensive care medicine with expertise or involvement in ECMO, from all ELSO chapters was assembled.

Each of the five-panel subgroups addressed a pre-selected clinical practice domain relevant to patients admitted to the ICU with ABI (ischemic stroke, ICH, or hypoxic-ischemic brain injury). Invited experts contributed to the guidelines through a three-phase process: (1) a literature search/review of neurological monitoring, management, and neurological ECMO outcomes, (2) summarizing the literature search/review, and (3) developing consensus guidelines using a modified Delphi method. The literature search and review performed comprehensively in PubMed on August 29, 2023 yielded up-to-date evidence on neurological monitoring and management strategies. Five key neurological areas needing recommendations were identified (see Introduction).

Guideline development

The selected articles were distributed to each subgroup. The subgroups summarized the findings and developed guidelines and recommendations for each subsection. Each subgroup nominated two leaders for cross-subgroup coordination. The consensus guideline members met regularly throughout the year in subgroup and whole-group settings to discuss their progress and reach a consensus on the finalized document. A modified Delphi process with three rounds of voting to assess the recommendation statements was implemented. Strong recommendation, weak recommendation, or no recommendation was defined when > 85%, 75–85%, and < 75% of panelists, respectively, agreed with a recommendation statement. Three rounds of voting and the authors’ comments about the expert consensus guideline appear in Supplemental Tables 1–3. The guidelines and recommendations were summarized and presented as 5 sections: (1) neurological assessment and monitoring; (2) bedside management; (3) interventional neurology, neurosurgery, and neurocritical care; (4) neurological prognostication; and (5) long-term outcome and quality of life.Table 3 Neurological monitoring tools in patients with ECMO support

Neuromonitoring tool	Evidence	
Near infrared spectroscopy (NIRS)	Several studies have shown that a large drop in rSO2 below baseline has been associated with brain injury [15, 16]. In a systematic review and meta-analysis on the role of rSO2 in ECPR, higher pre-cannulation rSO2 was associated with reduced mortality and better neurological outcomes [17]. Asymmetric desaturation (right-left) and the duration of desaturation may be better markers for ABI detection [15]. A few studies have utilized NIRS to identify disturbances in autoregulation [18, 19]	
Transcranial doppler ultrasound	Cerebral blood flow velocities and pulsatility index changes may be an early warning of ABI. In a prospective study of 135 patients, the absence of a pulsatility index was associated with a higher frequency of intraparenchymal hemorrhage and a composite bleeding event [20]. However, caution should be exercised in interpreting the pulsatility index, as in another case series of adult VA ECMO, patients’ low or absent pulsatility index was related to their cardiac output [21]. Similarly, microembolic signals in transcranial Doppler ultrasound needs further studies, as current evidence lacks correlation with the burden of microembolic signals to ABI [22]	
Pupillometry	Automated pupillometry can objectively evaluate pupil size and reactivity and provide reliable prognostication information [23]. Analysis of neurologic pupil index in 100 ECMO patients showed that a neurologic pupil index < 3 at any time 24–72 h after cannulation has 100% specificity for 90-day mortality, with 0% false positives [24]; however, no pupillometry data on neurological outcomes exist in ECMO. High opiate doses may affect the reliability of pupillometry assessment	
Electroencephalography (EEG)	The American Clinical Neurophysiology Society consensus statement (2015) recommended EEG monitoring for patients on ECMO who are at high risk for neurological complications such as seizures. Early EEG on ECMO can help in identifying non-convulsive seizures with an opportunity for early intervention [25, 26]. Poor background activity on continuous EEG has been associated with poor outcomes on ECMO [27–29] particularly in high-risk groups such as ECPR [30, 31]	
Somatosensory evoked potential (SSEP)	SSEP measure of cortical activity in response to stimuli in the peripheral nervous system has been utilized for neurological prognostication in comatose patients (especially for cardiac arrest). Application in the setting of ECMO, particularly in ECPR patients, may have a critical role. In a case series of 13 patients, Cho et al. showed that patients with a delayed response had poor neurological outcomes. However, in a subsequent cohort, the N20 responses remained intact despite poor neurological outcomes [29]. Further nvestigations are needed to determine the actual value of this diagnostic examination	
Head computed tomography (CT)	Most ECMO centers perform head CTs upon new clinical neurological concerns. However, studies of VV ECMO, VA ECMO, and ECPR have reported routine head CT within 24 h post-cannulation to be beneficial for early diagnosis of subclinical intracranial complications, such as large infarctions, hemorrhage, or edema, which may influence decisions on ECMO support management [32–36]. Limitations of head CT include poor sensitivity for detecting acute or small infarctions, and inability to transport hemodynamically unstable patients to the CT scanner. Early cessation and judicious resumption of anticoagulation appeared feasible in the cohort of patients with ECMO-associated ischemic stroke and ICH with the use of serial neuroimaging studies if feasible [37]	
Brain magnetic resonance imaging (MRI)	More than 30% of patients do not receive head CT scans during ECMO support due to transport restrictions and the lack of available transport personnel [7]. The gold standard for diagnosing ABI is represented by 1.5-3 T MRI, which is incompatible with extracorporeal life support circuits and equipment due to safety concerns (heating, migration, and malfunction). Recent advances in low-field (64 mT) and portable MRI technology enable the acquisition of clinically meaningful imaging in the presence of ferromagnetic materials. The safety and feasibility of portable MRI in adults with ECMO support were demonstrated [38]	
Serum biomarker	The most studied biomarkers include serum neuron-specific enolase and S100B, with higher values being significant predictors of mortality or neurological complications, especially if measured serially during ECMO support [39, 40]. However, the optimal timing and frequency of measurement, specific threshold values for outcome prediction, and methods to control for confounding effects have not been standardized	
ABI: acute brain injury; CT: computed tomography; ECMO: extracorporeal membrane oxygenation: ECPR: extracorporeal cardiopulmonary resuscitation; EEG: electroencephalography; ICH: intracranial hemorrhage; MRI: magnetic resonance imaging; NIRS: Near Infrared Spectroscopy; rSO2: regional tissue oxygen saturation; SSEP: somatosensory evoked potential; VA: venoarterial; VV: venovenous.

Neurological assessment and monitoring

Neurological examination

Serial bedside examination remains the mainstay of neurological assessment in ECMO patients. However, neurological evaluation, especially early after ECMO cannulation, is frequently confounded by sedatives and paralytics, necessitating noninvasive multimodal neurological monitoring in patients with impaired consciousness. The data on ABI timing to ECMO cannulation/support are limited. Therefore, a baseline neurological assessment is recommended before and immediately after cannulation, followed by serial evaluations throughout ECMO support and after weaning. The ideal frequency of neurological examination is not yet established. Daily assessment by a neurologist/neurointensivist (if available) can improve neurological care. [5, 7] More frequent bedside nursing assessment, every 1–4 h based on ABI risk, is reasonable. Particularly, assessing signs of life (such as gasping, pupillary light response, and increased consciousness) is integral to the clinical examination, as these signs observed before, during resuscitation, and while on ECMO support may be associated with improved neurological outcomes [8]. Historically, the absence of brainstem reflexes with fixed, dilated pupils before cannulation was equated to irreversible ABI and a contraindication to ECMO. However, during cardiopulmonary resuscitation (CPR), fixed and dilated pupils are frequently seen after epinephrine administration, and patients have achieved favorable outcomes despite these findings [9].

Serial neurological examination should include mental status assessment, brainstem reflexes (pupillary light response and oculocephalic, corneal, and cough/gag reflexes), and motor exam. Standardized scoring tools such as the Glasgow Coma Scale and the Confusion Assessment Method should be used. Assessing the motor response of extremities in neurological examinations is only helpful when analgo-sedation and paralytic is lightened or off. Therefore, neurological exam for spinal cord injury, a rare but devastating injury, is very challenging [10]. Sensory exams are mostly limited in ECMO patients.

Sedation

Adequate analgo-sedation is essential to ECMO support and minimizes adverse events [11]. ECMO circuitry and common concomitant impaired liver or kidney function alter medication pharmacokinetics. Standardized sedation protocols with validated scoring systems, such as the Richmond Agitation Sedation Scale, are recommended. Overall, intermittent (as-needed) analgo-sedation is preferred over continuous infusion. Short-acting, non-benzodiazepine sedatives could be considered [11]. Daily reassessment of sedation goals, stepwise sedation weaning, and sedation interruptions can improve neurological exams and ABI diagnosis [11].

Neurological monitoring

Standardized neurological monitoring, clinical assessment, and a sedation cessation protocol may increase ABI detection and improve neurological outcomes [8, 12]. In a single-center study (90% VA ECMO), autopsy shortly after ECMO decannulation showed that 68% of ECMO non-survivors had developed ABI [13]. In another cohort, 9 of 10 brains exhibited ABI at autopsy [14], suggesting that ABI incidence is likely higher than clinical detection. Early, accurate ABI detection with standardized neurological monitoring and early interventions is critical for mitigating ABI. Table 3 summarizes current neurological monitoring tools and their evidence (Supplemental Fig. 1), and Table 4 provides the consensus recommendations on neurological monitoring (Fig. 1). A concise review of sedation, disorders of consciousness and seizure is separately summarized in Supplemental File 1.Fig. 1 Recommendations for neurological monitoring and neuroimaging on ECMO. ABI: acute brain injury; EEG: electroencephalography; rSO2: regional oxygen saturation; SSEP: somatosensory evoked potential; VA ECMO: venoarterial extracorporeal membrane oxygenation

Table 4 Consensus recommendations based on modified Delphi on neuromonitoring/neuroimaging tools during ECMO

Recommendations	References	
1. Neuromonitoring/Neuroimaging*	
1.1 Standardized neuromonitoring and neurological expertise for ECMO patients who are at high risk of developing ABI are recommended	[6, 32]	
1.2. Continuous cerebral oximetry, to follow ongoing trends and early detection of ABI, especially for those with peripheral VA ECMO, who are at risk for differential hypoxia, is recommended	[15, 16, 18, 19]	
1.3. Intermittent EEG and SSEP, particularly in comatose patients, are recommended. If available, continuous EEG is especially useful to detect non-convulsive seizures in comatose patients	[25]	
1.4. Pupil assessment is recommended. If available, the use of pupillometry should be considered	[7, 37]	
1.5. Early neuroimaging for ECMO patients at risk of ABI based on physical examination and neuromonitoring tools is recommended	[32, 34–36]	
ABI: acute brain injury; ECMO: extracorporeal membrane oxygenation; EEG: electroencephalography; SSEP: somatosensory evoked potential; VA: venoarterial.

*Results of the Delphi survey results are available in the Supplementary Material.

Bedside management

Arterial oxygen

The brain depends on aerobic glucose metabolism for energy, with an average cerebral consumption of 3.5 mL oxygen per 100 g of brain tissue per minute. Hyperoxemia (partial pressure of oxygen (PaO2) > 100 or 120 mmHg: mild; > 300 mmHg: severe) and hypoxemia (PaO2 < 60 or 70 mmHg) are associated with increased mortality in ICU patients, including subjects on ECMO [41, 42].

VV ECMO

Limited data exist on early (first 24 h) oxygen targets and neurological outcomes after VV ECMO cannulation. In a single-center observational cohort study, PaO2 < 70 mmHg (hypoxemia) was associated with ABI, especially ICH [43]. There are no data on hyperoxemia as it is not often an issue clinically in VV ECMO patients.

VA ECMO

In VA ECMO, when the heart recovers before lung recovery, cerebral hypoxemia (especially of the right side of the brain) may occur due to the “differential oxygenation” (also called “Harlequin Syndrome” or “North–South Syndrome”), which is monitored by arterial blood gases from right radial arterial line, especially for those supported with peripheral VA ECMO. Monitoring of cerebral oxygenation using NIRS may be useful in diagnosing differential oxygenation [15].

Severe hyperoxemia (PaO2 > 300 mmHg) within 24 h after the cannulation may be associated with ABI and poor neurologic outcomes [4, 42, 44]. As optimal oxygenation targets are unknown, it is reasonable to avoid early (within 24 h) severe hyperoxemia and hypoxemia by manipulating the fraction of delivered oxygen from the ECMO sweep gas (Fig. 2). Given the high-quality data are limited, it is crucial to prospectively study the impact of hyperoxemia on ABI and neurological outcomes in VA ECMO as a multi-institutional study with protocolized neurological monitoring and diagnostic ABI adjudication. Importantly, further research is necessary to investigate the impact of hyperoxemia on each major VA ECMO cohort: postcardiotomy shock, ECPR, and post-acute myocardial infarction (AMI) as well as non-AMI cardiogenic shock.Fig. 2 Recommendations for bedside management on ECMO. ABG: arterial blood gas; BP: blood pressure; ECMO: extracorporeal membrane oxygenation; MAP: mean arterial pressure; PaCO2: partial pressure of carbon dioxide; PaO2: partial pressure of oxygen; VA: venoarterial; VV: venovenous

Arterial carbon dioxide

Severe acidosis and hypercapnia are common before ECMO cannulation, and both are rapidly corrected upon ECMO initiation by adjusting sweep gas flow across the oxygenator. Carbon dioxide is a potent cerebral vasodilator that increases cerebral blood flow[45] and neuronal metabolic demand [46]. Prolonged hypercapnia, common in pre-ECMO patients, may impair cerebral autoregulation, leading to high cerebral blood flow and a narrow regulatory pressure window [40, 47]. While high partial pressure of carbon dioxide (PaCO2) should be avoided, rapid correction of sustained high PaCO2, particularly soon after ECMO initiation, sometimes leads to rapid hypocapnia; it may cause cerebral vasoconstriction and a decrease in cerebral oxygen delivery, resulting in cerebral ischemia [46]. Routine use of full-dose anticoagulation therapy at ECMO initiation and thereafter may cause hemorrhagic conversion of an ischemic injury.

VV ECMO

In an ELSO registry analysis, a rapid early decrease in PaCO2 was independently associated with an increased risk of ICH in ARDS patients with VV ECMO [48]. An ELSO retrospective study of 11,972 VV ECMO patients showed that those with ΔPaCO2 > 50% in the peri-cannulation period were more likely to experience ABI (infarct and ICH) [49].

VA ECMO

A higher ΔPaCO2 in VA ECMO was associated with ICH in a single-center observational study [50]. However, an ELSO retrospective study of 3125 ECPR patients showed ΔPaCO2 higher in ABI than non-ABI, but ΔPaCO2 was not significantly associated with ABI [4]. These findings are limited by (a) a lack of sensitive, reliable, and readily available diagnostic markers of ABI, (b) retrospective observations, and (c) inconsistent arterial blood gas sampling. Further research with standardized neurological diagnostic/monitoring tools and granular arterial blood gas data is necessary. However, avoiding a large ΔPaCO2 > 50% in the peri-cannulation period for both VA and VV ECMO is reasonable.

Temperature

Inducing hypothermia during ischemia prolongs the tolerance of organs to ischemia, improving neurological outcomes [51]. Thus, it could be reasonable to use hypothermia in VA ECMO patients where cerebral ischemic and hypoperfusion time is prolonged. This rationale is even more important in patients who have already suffered severe hypoxic-ischemic brain injury, as in ECPR. However, as demonstrated by a meta-analysis of 2643 ECPR patients (35 studies), data on this topic are severely heterogeneous and limited to low-quality evidence [52]. One randomized controlled trial on cardiogenic shock patients requiring VA ECMO compared moderate hypothermia (33–34 °C) versus normothermia (36–37 °C), showing no mortality difference at 30 days [53]. This study was limited by (1) insufficient sample size due to inaccurate effect size estimation based on non-ECMO studies, (2) lack of formal neurological assessment, and (3) primary outcome being mortality outcome at 30 days instead of neurological outcomes at 90 or 180 days. The basic and preclinical science on hypothermia in ischemia is strong, and VA ECMO patients have a high incidence of ABI and prolonged absent/low cerebral perfusion. Also, bleeding complications and coagulopathy were similar between those with hypothermia vs. without in a meta-analysis of ECPR patients [52]. A robust multicenter prospective observation cohort study is needed to test the effect of hypothermia strategically in each major VA ECMO cohort. There is no data on hypothermia in VV ECMO patients.

Blood pressure

No data exists on early and optimal blood pressure (BP) goals and ABI prevention, especially for stroke or hypoxic-ischemic brain injury, as the timing of ABI is not well-defined during the peri-cannulation period. After acute ischemic stroke, permissive hypertension (BP ≤ 220/120 mmHg) is recommended by the AHA[54]; it is reasonable to target mean arterial blood pressure (MAP) that can provide adequate cerebral perfusion in the setting of acute ischemic stroke.

Higher BPs lead to increased afterload, which may hinder myocardial recovery (VA ECMO only), particularly when the left ventricle is not vented. In the absence of high-quality data, allowing patients with acute ischemic stroke to autoregulate is reasonable if the heart can tolerate it. After ICH, lower BP (systolic BP < 140 mmHg and MAP < 90 mmHg) is preferred due to anticoagulation-associated ICH [55]. Cerebral autoregulation function in the setting of non-pulsatile blood flow and ABI is an active research area, and autoregulatory dysfunction may contribute to ABI in ECMO (Supplemental File 2) [56].

Low pulse pressure (< 20 mmHg) in the first 24 h of VA ECMO was associated with ABI [57]. However, data are weak regarding improving pulse pressure with inotropes, or left ventricle venting in ECMO [58]. Evidence on BP goals for optimal cerebral perfusion in ECMO patients is sparse. Yet, individualized BP management tailored to dynamic cerebral autoregulation function is likely needed in this complex population. However, evidence as well as related therapeutic actions in this regard are still limited and represent mandatory objectives for future research to enhance ECMO patient management and most likely ABI complications prevention and/or reduction. A summary of consensus recommendations and evidence appears in Table 5 and Supplemental Table 4.Table 5 Consensus recommendations based on modified Delphi on bedside physiological targets for ECMO patients for ABI

Recommendations	References	
2. Bedside management*	
2.1. Serial arterial blood gas sampling in the first 24 h of ECMO support is recommended	[4, 41, 42]	
2.2. Avoiding arterial hypoxemia (PaO2 < 70 mmHg) is recommended	[4, 41, 42]	
2.3. Avoiding severe arterial hyperoxia (PaO2 > 300 mmHg), especially for VA ECMO where reperfusion injury risk is high, is recommended	[42, 44]	
2.4. For patients with hypercapnia (PaCO2 > 45 mmHg), avoiding rapid change in PaCO2 within the first 24 h of ECMO support is recommended	[48]	
2.5. Continuous monitoring of core temperature and active prevention of fever (> 37.7 °C) are recommended	[51, 52]	
2.6. Mild-moderate hypothermia (33–36 °C) for 24–48 h in VA ECMO, especially ECPR, is reasonable and may be considered	[51–53]	
2.7. Hypothermia in VV ECMO is not recommended	[51–53]	
2.8. As optimal ECMO flow and blood pressures are unknown, avoiding hypotension and maintaining mean arterial pressure > 70 mmHg should be considered. Individualized BP goals, based on the patient’s comorbidities, are recommended until further data are available	[55, 56]	
2.9. Individualized blood pressure management in ECMO patients, tailored to dynamic cerebral autoregulation function may be reasonable	[58]	
ECMO: extracorporeal membrane oxygenation; ABI: acute brain injury; ECPR: extracorporeal pulmonary resuscitation; PaCO2: partial pressure of carbon dioxide; PaO2: partial pressure of oxygen; VA: venoarterial; VV: venovenous.

*Results of the Delphi survey results are available in the Supplementary Material.

Interventional neurology, neurosurgery, and neurocritical care

ABI diagnosis in ECMO patients is based on comprehensive neurological assessment and brain imaging. Neurological assessment for acute stroke should include the Glasgow Coma Scale and the National Institutes of Health Stroke Scale. Non-contrast head CT is imperative to rule out ICH with acute neurological exam change. CT angiogram is needed to assess for large vessel occlusion.

Brain perfusion optimization

Managing intracranial pressure (ICP) and BP contributes to adequate brain perfusion in ABI patients. Elevating the head of the bed by 30 degrees might benefit patients with ABI and elevated ICP [61]. However, brain oxygenation and circulation improve in the supine position, benefiting perfusion-dependent patients with acute ischemic strokes. The head of the bed could be guided by monitoring surrogate markers of cerebral hemodynamics (i.e., transcranial Doppler ultrasound: cerebral blood flow velocity) and oxygenation (i.e., NIRS: regional saturation) [62, 63]. If the heart can tolerate a higher BP, it’s reasonable to target a higher BP target (although individualized BP goal is recommended) to achieve adequate cerebral perfusion pressure, such as permissive hypertension for ischemic stroke. However, increased BP is associated with hematoma extension in ICH, so reducing BP (systolic BP < 140 mmHg) is reasonable, as ECMO patients are usually on full anticoagulation at the time of ICH.

Managing ischemic stroke

Tissue plasminogen activator (tPA)

Non-contrast head CT is imperative to rule out bleeding in acute neurological change, particularly during ECMO. tPA is a time-dependent intervention in acute ischemic stroke. Intravenous tPA in the setting of ECMO carries a high risk of bleeding, especially with systemic anticoagulation and platelet dysfunction. Given these risks, the use of tPA is generally not indicated in ECMO patients. Although there is limited literature specifically addressing this issue, the consensus among experts is to avoid tPA (Fig. 3).Fig. 3 Recommendations for interventional neurology, neurosurgery & neurocritical care on ECMO. CT: computed tomography; ECMO: extracorporeal membrane oxygenation; ICH: intracranial hemorrhage; ICP: intracranial pressure; PbtO2: brain tissue oxygenation; tPA: tissue plasminogen activator; VV: venovenous; VA: venoarterial

Mechanical thrombectomy

CT angiogram is needed to rule out large vessel occlusion, typically accompanied by a CT perfusion scan to assess salvageable penumbra. Mechanical thrombectomy should be pursued for patients with large vessel occlusion detected by CT angiogram (accompanied by a CT perfusion scan to assess salvageable penumbra), by consulting stroke specialists, as tPA is generally not recommended in ECMO [64].

Decompressive craniectomy

Decompressive craniectomy may be indicated in patients with space-occupying lesions with acute intracranial hypertension, such as hemispheric infarction with malignant edema. Hyperosmolar therapy is indicated for cerebral edema [1]. Systemic anticoagulation monitoring and resumption are necessary post-operatively. Successful craniectomy has been reported for patients on ECMO [65]. As evidence is limited, the risks versus benefits of such an intervention should be judiciously discussed in a multidisciplinary manner.

Managing ICH

There are two primary considerations in ICH management. First, preventing hematoma expansion by BP control and discontinuing systemic anticoagulation is recommended. The duration of systemic anticoagulation varies based on the mode of ECMO. VV ECMO may allow anticoagulation discontinuation until decannulation based on multiple reports of heparin-free VV ECMO with a heparin-coated circuit [66]. In contrast, holding systemic anticoagulation carries a higher risk of thromboembolism with VA ECMO, especially the ECMO circuit [67, 68]. Early cessation without reversal and judicious resumption of anticoagulation with repeated neuroimaging appeared feasible in the cohort of patients with ECMO-associated ischemic stroke and ICH [37]. Second, surgical or minimally invasive surgery hematoma evacuation may be considered. There is limited data on neurosurgical interventions in ECMO[69] for patients with no other management options. Neurosurgery may be considered and utilized. Multidisciplinary discussion should be undertaken, involving neurosurgeons and neurologists in decision-making.

Intracranial pressure monitoring

While external ventricular drainage may be indicated in patients with ICH with intraventricular extension and hydrocephalus, ECMO is associated with coagulopathy and requires systemic anticoagulation. Therefore, external ventricular drain insertion is a high-risk procedure associated with intra- and post-procedural bleeding [69]. External ventricular drain may be considered in selected patients at risk of imminent death from intraventricular hemorrhage and hydrocephalus. Monitoring ICP or invasive brain tissue oxygenation may be used in patients at high risk of ICP. Invasive ICP and brain tissue oxygenation have not been shown to improve long-term outcomes and may increase the risk of parenchymal hemorrhage in ECMO patients.

Cerebral venous sinus thrombosis (CVST)

Diagnosis of CVST requires a high index of suspicion in patients with risk factors for thrombosis, including internal jugular vein cannulation. Particularly, large dual-lumen VV ECMO cannulas may be associated with ABI, possibly due to venous hypertension and cannula-related thrombosis [70]. Clinical diagnosis is challenging because of varying neurological manifestations, including non-specific symptoms such as headache, seizure, or encephalopathy [71]. The diagnosis is made with brain CT in ECMO. Systemic anticoagulation is the primary treatment; however, in deteriorating patients, endovascular mechanical thrombectomy in advanced centers may be considered [72]. Lumbar puncture or other spinal fluid drainage and acetazolamide may be considered for patients with increased ICP, along with anti-edema interventions (raising the head of the bed, hyperosmolar therapy, sedation/analgesia, etc.) [73]. In severe CVST cases with hemispheric cerebral edema, decompressive craniectomy may be considered. A summary of consensus recommendations and evidence is provided in Table 6 and Supplemental Table 5.Table 6 Consensus recommendations based on modified Delphi on neurological intervention and management for ECMO patients with ABI

Recommendations	References	
3. Interventional neurology, neurosurgery, and neurocritical care*	
3.1. Neurological consultation for acute neurological change is recommended	[6, 12]	
3.2. Non-contrast head CT, to rule out ICH in patients with suspected stroke during ECMO, is recommended	[32–36]	
3.3. tPA is not recommended for acute ischemic stroke in ECMO, since tPA carries a high risk of bleeding during systemic anticoagulation and platelet dysfunction		
3.4. Mechanical thrombectomy, in cases of acute large vessel occlusion, is recommended	[64]	
3.5. Stepwise acute intracranial hypertension management is recommended	[1, 61]	
3.6. The decision of decompressive craniectomy for stroke, based on a risk–benefit discussion between the multidisciplinary medical team and the patient surrogate, is recommended	[65, 69]	
3.7. Careful systemic anticoagulation monitoring and resumption after decompressive craniectomy are recommended	[37]	
3.8. For acute intracranial hemorrhage during VV ECMO, prolonged (> 2 days) cessation of systemic anticoagulation is recommended	[37, 66]	
3.9. VA ECMO can be maintained without anticoagulation albeit at a higher risk of thromboembolism. It is recommended that clinicians should balance the risk of anticoagulation and bleeding against the risk of running VA ECMO with no systemic anticoagulation. VV ECMO can be maintained without anticoagulation for a longer period than VA ECMO, given the lower risk of thromboembolism	[67]	
3.10. Early cessation and judicious resumption of anticoagulation with repeated neuroimaging with ECMO-associated ischemic stroke and intracranial hemorrhage is recommended	[37, 66]	
3.11. Data on anticoagulation reversal in ECMO are limited, and therefore no recommendation is provided		
3.12. Extra-ventricular drain placement, in patients with limited management options and high risk of death due to intraventricular hemorrhage and hydrocephalus, may be considered	[69]	
3.13. Monitors measuring intracranial pressure and/or brain tissue oxygenation should be considered cautiously, as no data currently suggests that such monitoring improves outcomes in patients with ECMO	[69]	
CT: computed tomography; ECMO: extracorporeal membrane oxygenation; ICH: intracranial hemorrhage; tPA: tissue plasminogen activator; VA: venoarterial; VV: venovenous.

*Results of the Delphi survey results are available in the Supplementary Material.

Neurological prognostication

ECPR

Neurological prognostication is imperative in patients supported by ECPR, in which severe hypoxic-ischemic brain injury may occur as a consequence of refractory cardiac arrest and/or due to inadequate ECMO flow and differential hypoxia. It provides families and caregivers critical information and guides treatment decisions based on the likelihood of a meaningful neurological recovery. As the data on neurological prognostication is limited [74], a comprehensive approach to prognostication is needed.

Clinical examination plays a pivotal role in prognostication. Practitioners should first rule out potential confounding factors, such as sedatives, significant electrolyte disturbances, and hypothermia, to prevent an overly pessimistic prognosis. Daily clinical/neurological assessments are recommended for patients undergoing targeted temperature management, with the most crucial evaluation conducted after rewarming [74]. Attention should be given to pupillary and corneal reflexes [75, 76]. Clinicians must exercise caution to mitigate the “self-fulfilling prophecy” bias, which occurs when prognostic test results indicating poor outcomes influence treatment decisions [77].

A comprehensive prognostication strategy should include electrophysiological tests, the evaluation of biomarkers of ABI, and neuroimaging (Table 7). Notwithstanding, new modalities are under investigation and will hopefully provide additional clues in such a setting regarding early and enhanced detection of ABI as well as prognostication in ECMO patients [78, 79]. An unfavorable neurological outcome in patients without ECMO and cardiac arrest is strongly suggested by at least two indicators of severe ABI. These include the absence of pupillary and corneal reflexes at ≥ 72 h, bilateral lack of N20 cortical waves in somatosensory evoked potentials (SSEP) at ≥ 24 h, highly malignant EEG patterns at > 24 h, neuron-specific enolase levels exceeding 60 μg/L at 48 h or 72 h, status myoclonus ≤ 72 h, and extensive diffuse anoxic injury observed on brain CT/MRI [74, 80]. This approach has not been validated in ECMO patients and has limited evidence [30].Table 7 Consensus recommendations on neurological prognostication for ECMO patients

Recommendations	References	
4. Neurological prognostication*	
4.1. Neurological prognostication for ECPR based on a multimodality, multidisciplinary approach of clinical/neurological examination, electrophysiological tests, and neuroimaging is recommended	[30]	
4.2. It is not recommended to use any single factor/tool (e.g. brain imaging only) as the sole indicator for patient prognosis	[30]	
4.3. Determination of brain death, based on the presence of devastating brain injury on imaging, neurological examination, and apnea test after considering official recommendations, guidelines, and laws of the specific country and excluding confounding factors is recommended. When an apnea test is challenging, cerebral angiogram or nuclear scan (radionuclide brain scan) are preferred ancillary tests	[75, 76, 81]	
4.4. Frequent meetings and goals of care discussions with the patient surrogate that reflect the patient’s preferences is recommended	[82–84]	
ECPR: extracorporeal cardiopulmonary resuscitation.

*Results of the Delphi survey results are available in the Supplementary Material.

Neuron-specific enolase values are often higher in ECMO patients due to ongoing hemolysis [30, 85]. The most accurate neuron-specific enolase threshold for predicting an unfavorable neurological outcome in ECPR remains unknown, possibly exceeding 100 μg/L. There are sparse data on ECMO patients regarding other biomarkers, such as neurofilament light chain or tau. A combination of clinical, biomarker, electrophysiological, and neuroimaging assessment may effectively predict a neurological outcome within the first week following cardiac arrest [81]. However, limited data exist for this approach in ECMO patients; further research is needed to validate its utility. A summary of consensus recommendations and evidence is provided in Table 7.

Other neurological diseases

Neurological prognostication in other ABI (non-hypoxic-ischemic brain injury) with ECMO is challenging and relies on less robust data than cardiac arrest. In the context of stroke (ischemic and hemorrhagic), clinical factors impacting outcomes include neurological exam, age, functionality (i.e., modified Rankin Scale), size, and stroke location. For example, age and the location of intracerebral hemorrhage may contribute to neurological prognosis [86]. However, decisions regarding withdrawal of life-sustaining therapy should be highly individualized with multidisciplinary discussions and considered patient preferences, as data on ECMO patients are sparse.

ICH while the patient is anticoagulated during ECMO carries extremely high mortality and morbidity, as shown in large ELSO registry-based investigations [87, 88]. However, these studies did not account for withdrawing life-sustaining therapy in ECMO. Without data, no recommendations for neurological prognostication in ECMO patients can be made.

Brain death on ECMO

A systematic review reported that an apnea test could be included in brain-death criteria in ECMO patients by reducing sweep gas flow or adding exogenous carbon dioxide [89]. When an apnea test is challenging due to hemodynamic/cardiopulmonary instability, a cerebral angiogram or nuclear scan (radionuclide brain scan) is preferred [89]. We provide recommendations on apnea tests in ECMO patients (Supplemental Fig. 2).

Goals of care discussion

Goals of care and end-of-life discussions are often culturally influenced or determined. Therefore, it is difficult to propose international guidelines for such. No patient-level research guides communicating with families or managing ECMO discontinuation [82]. Families of ECMO patients experience significant anxiety, depression, and post-traumatic stress disorder long after hospital discharge [83]. Frequent family conversations/meetings should focus on informed consent, early goal-setting with timelines and re-evaluation, clear communication, and emotional support with compassion [82]. Ethics should be discussed openly, including whether to continue or discontinue care and resource allocation issues [82]. Routine use of ethics consultation within 72 h of cannulation, if the resource is available, can mitigate ethical conflicts by setting clear expectations [84]. Withdrawal from ECMO should be a structured process involving preparatory family meetings and clinical aspects, including symptom management, technical circuit management, and bereavement support, containing family and staff support.[90].

Long-term outcome and quality of life

Sparse information exists on long-term outcomes. Long-term MRI found cerebral infarction or hemorrhage in 37–52% of adult ECMO survivors [59, 60]. Cognitive impairment and neuroradiologic findings were associated [59, 60]. ECMO patients often suffer long-term psychiatric disorders, including organic mental disorders, obsessive–compulsive disorders, and post-traumatic stress disorders [91]. The incidence of neuroradiologic findings was significantly higher in VA ECMO patients than VV ECMO patients [59]. Given the high frequency, a routine, long-term, structured, standardized follow-up program is recommended for all ECMO centers. Such programs should encompass disease-specific care for underlying and acquired conditions, focusing on neurological and psychiatric disorders. Program design depends on the availability of institutional and international resources. ECMO centers should adapt follow-up programs their specific patient populations and resources while adhering to the recommendations outlined in Table 8.Table 8 Consensus recommendations on long-term neurological outcomes and follow-ups for ECMO patients

Recommendations	References	
5. Long-term outcomes and quality of life*	
 5.1. Pre-discharge care	
  5.1.1 Clinical examination and use of the modified Rankin Scale before the discharge are recommended. Neuroimaging (preferably conventional MRI brain after decannulation) for those with neurological or cognitive dysfunction is reasonable	[59, 60]	
  5.1.2 Outpatient care planning, with careful consideration of the timing of visits (preferably at 3, 6, and 12 months) after discharge, location of visits (preferably at ECMO clinics or neurologist), and ECMO-related comorbidities and complications (vascular, myopathy, chronic infection, cardiopulmonary recovery) is recommended	[59, 60]	
  5.1.3 Comprehensive education and psychosocial support for patients, family members, and caretakers are recommended	[59, 60, 92]	
  5.1.4 Assessment and formulation of a nutritional plan for optimal recovery is recommended		
 5.2. Post-discharge care	
  5.2.1 Serial neurological assessments and quality of life assessments are recommended	[59, 60]	
  5.2.2 In patients with neurological complications, clinical examination by a neurological specialist, neuroimaging (preferably MRI), and other tailored examinations/tests are recommended	[59, 60]	
  5.2.3 Follow up with disease-specific specialists that are tailored to the underlying disease and comorbidities, including pulmonologist, cardiologist, neurologist, nephrologist, gastroenterologist, and hematologist, is recommended as needed	[59]	
  5.2.4 Follow up with the primary care physician is recommended	[60]	
  5.2.5 Establishing a centralized and secure data repository to store patient data that can be shared with outpatient healthcare providers is recommended	[93]	
ECMO: extracorporeal membrane oxygenation; MRI: magnetic resonance imaging.

*Results of the Delphi survey results are available in the Supplementary Material.

Neurological outcomes and quality of life

Assessing ECMO survivors’ quality of life is crucial to understanding the overall impact of ECMO. It is preferable to use internationally recognized, validated tests at standardized intervals. Establishing uniform measures of cognitive function in ECMO patients may clarify outcomes in future studies. Therefore, all patients should have their modified Rankin Scale assessed at discharge and during each follow-up. Additional detailed assessments may be performed based on local practices and patient conditions (e.g., Glasgow Outcome Scale Extended, Montreal Cognitive Assessment). A summary of consensus recommendations and evidence is provided in Table 8 and Supplemental Fig. 3.

Conclusions

The impact of ABI on morbidity and mortality in ECMO patients is high, and early ABI detection and timely intervention may improve outcomes. Therefore, standardized neurological monitoring and neurological expertise are recommended for ECMO patients. These consensus recommendations and scientific statements serve to guide the neurological monitoring and prevention of ABI, and management strategy of ECMO-associated ABI These recommendations strongly benefit from multidisciplinary care, where it is available, to maximize the chances of favorable long-term outcomes and a good quality of life. Further research on predisposing factors, prevention, neuroimaging and management are ongoing or further required in an attempt to reduce or prevent such dreadful adverse events in ECMO patients.

Supplementary Information

Additional file1

Abbreviations

ABI Acute brain injury

AMI Acute myocardial infarction

BP Blood pressure

CT Computed tomography

ECMO Extracorporeal membrane oxygenation

ECPR Extracorporeal cardiopulmonary resuscitation

EEG Electroencephalogram

ELSO Extracorporeal Life Support Organization

ICH Intracranial hemorrhage

ICP Intracranial pressure

ICU Intensive care unit

MRI Magnetic resonance imaging

NIRS Near-infrared spectroscopy

PaCO2 Partial pressure of carbon dioxide

PaO2 Partial pressure of oxygen

rSO2 Regional oxygen saturation

SSEP Somatosensory evoked potential

tPA Tissue plasminogen activator

VA Venoarterial

VV Venovenous

Author contributions

S.-M.C. prepared the first draft, led the conceptualization and approach, and finalized the guidelines. A.M.Z. and R.L. provided critical revision and contributed in finalizing the guidelines as co-chairs. J.H. and G.C. provided tables and contributed to the first draft. M.A. created all figures and supplemental figures. M.A., N.B., J.B., D.B., H.J.D, R.D., A.E., P.T.F., H.F., J.F., A.H., J.-S.J., C.L., G.M., G.P., A.P., J.P., L.R., K.R., D.D., D.R., L.S., F.S.T., and G.W. were divided into 6 writing groups and prepared each section of the guidelines (6 sections).

Funding

Dr. Cho is supported by NIH (1K23HL157610, 1R21NS135045). Dr. Brodie received research support from and consults for LivaNova.

Availability of data and materials

No datasets were generated or analysed during the current study.

Declarations

Ethical approval and consent to participate

Not applicable as this is a consensus guidelines article.

Competing interests

Dr. Cho is a consultant for Hyperfine, Inc. and supported by NIH (1K23HL157610 and 1R21NS135045). Dr. Brodie received research support from and consults for LivaNova. He has been on the medical advisory boards for Xenios, Medtronic, Inspira, and Cellenkos. He is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the Chair of the Executive Committee of the International ECMO Network (ECMONet), and he writes for UpToDate. Dr. Daniel is supported by MH CZ (DRO-VFN64165) and receives consulting honoraria from Abiomed and Resuscitec. Dr. Lorusso received research support from Medtronic and LivaNova, is consultant for Medtronic and Livanova, Member of the Medical Advisory Board of Eurosets and Xenios, and receives speaker fee from Abiomed.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Akram M. Zaaqoq and Roberto Lorusso have contributed equally as senior authors.
==== Refs
References

1. Cho SM Farrokh S Whitman G Bleck TP Geocadin RG Neurocritical care for extracorporeal membrane oxygenation patients Crit Care Med 2019 47 12 1773 1781 10.1097/CCM.0000000000004060 31599814
Cho SM, Farrokh S, Whitman G, Bleck TP, Geocadin RG. Neurocritical care for extracorporeal membrane oxygenation patients. Crit Care Med. 2019;47(12):1773–81.31599814 10.1097/CCM.0000000000004060
2. Lorusso R Gelsomino S Parise O Di Mauro M Barili F Geskes G Vizzardi E Rycus PT Muellenbach R Mueller T Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database Crit Care Med 2017 45 8 1389 1397 10.1097/CCM.0000000000002502 28538440
Lorusso R, Gelsomino S, Parise O, Di Mauro M, Barili F, Geskes G, Vizzardi E, Rycus PT, Muellenbach R, Mueller T, et al. Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the extracorporeal life support organization database. Crit Care Med. 2017;45(8):1389–97.28538440 10.1097/CCM.0000000000002502
3. Ubben JFH Heuts S Delnoij TSR Suverein MM van de Koolwijk AF van der Horst ICC Maessen JG Bartos J Kavalkova P Rob D Extracorporeal cardiopulmonary resuscitation for refractory OHCA: lessons from three randomized controlled trials-the trialists' view Eur Heart J Acute Cardiovasc Care 2023 12 8 540 547 10.1093/ehjacc/zuad071 37480551
Ubben JFH, Heuts S, Delnoij TSR, Suverein MM, van de Koolwijk AF, van der Horst ICC, Maessen JG, Bartos J, Kavalkova P, Rob D, et al. Extracorporeal cardiopulmonary resuscitation for refractory OHCA: lessons from three randomized controlled trials-the trialists’ view. Eur Heart J Acute Cardiovasc Care. 2023;12(8):540–7.37480551 10.1093/ehjacc/zuad071
4. Shou BL Ong CS Premraj L Brown P Tonna JE Dalton HJ Kim BS Keller SP Whitman GJR Cho SM Arterial oxygen and carbon dioxide tension and acute brain injury in extracorporeal cardiopulmonary resuscitation patients: analysis of the extracorporeal life support organization registry J Heart Lung Transplant 2023 42 4 503 511 10.1016/j.healun.2022.10.019 36435686
Shou BL, Ong CS, Premraj L, Brown P, Tonna JE, Dalton HJ, Kim BS, Keller SP, Whitman GJR, Cho SM. Arterial oxygen and carbon dioxide tension and acute brain injury in extracorporeal cardiopulmonary resuscitation patients: analysis of the extracorporeal life support organization registry. J Heart Lung Transplant. 2023;42(4):503–11.36435686 10.1016/j.healun.2022.10.019
5. Ong CS Etchill E Dong J Shou BL Shelley L Giuliano K Al-Kawaz M Ritzl EK Geocadin RG Kim BS Neuromonitoring detects brain injury in patients receiving extracorporeal membrane oxygenation support J Thorac Cardiovasc Surg 2023 165 6 2104 2110 10.1016/j.jtcvs.2021.09.063 34865837
Ong CS, Etchill E, Dong J, Shou BL, Shelley L, Giuliano K, Al-Kawaz M, Ritzl EK, Geocadin RG, Kim BS, et al. Neuromonitoring detects brain injury in patients receiving extracorporeal membrane oxygenation support. J Thorac Cardiovasc Surg. 2023;165(6):2104–10.34865837 10.1016/j.jtcvs.2021.09.063
6. Shoskes A Migdady I Rice C Brain injury is more common in venoarterial extracorporeal membrane oxygenation than venovenous extracorporeal membrane oxygenation: a systematic review and meta-analysis Crit Care Med 2020 48 12 1799 1808 10.1097/CCM.0000000000004618 33031150
Shoskes A, Migdady I, Rice C, et al. Brain injury is more common in venoarterial extracorporeal membrane oxygenation than venovenous extracorporeal membrane oxygenation: a systematic review and meta-analysis. Crit Care Med. 2020;48(12):1799–808. 10.1097/CCM.0000000000004618.33031150 10.1097/CCM.0000000000004618
7. Cho SM Ziai W Mayasi Y Gusdon AM Creed J Sharrock M Stephens RS Choi CW Ritzl EK Suarez J Noninvasive neurological monitoring in extracorporeal membrane oxygenation ASAIO J 2020 66 4 388 393 10.1097/MAT.0000000000001013 31045914
Cho SM, Ziai W, Mayasi Y, Gusdon AM, Creed J, Sharrock M, Stephens RS, Choi CW, Ritzl EK, Suarez J, et al. Noninvasive neurological monitoring in extracorporeal membrane oxygenation. ASAIO J. 2020;66(4):388–93.31045914 10.1097/MAT.0000000000001013
8. Debaty G Lamhaut L Aubert R Nicol M Sanchez C Chavanon O Bouzat P Durand M Vanzetto G Hutin A Prognostic value of signs of life throughout cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest Resuscitation 2021 162 163 170 10.1016/j.resuscitation.2021.02.022 33609608
Debaty G, Lamhaut L, Aubert R, Nicol M, Sanchez C, Chavanon O, Bouzat P, Durand M, Vanzetto G, Hutin A, et al. Prognostic value of signs of life throughout cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest. Resuscitation. 2021;162:163–70.33609608 10.1016/j.resuscitation.2021.02.022
9. Desai M Wang J Zakaria A Dinescu D Bogar L Singh R Dalton H Osborn E Fixed and dilated pupils, not a contraindication for extracorporeal support: a case series Perfusion 2020 35 8 814 818 10.1177/0267659120915386 32404027
Desai M, Wang J, Zakaria A, Dinescu D, Bogar L, Singh R, Dalton H, Osborn E. Fixed and dilated pupils, not a contraindication for extracorporeal support: a case series. Perfusion. 2020;35(8):814–8.32404027 10.1177/0267659120915386
10. Le Guennec L Shor N Levy B Lebreton G Leprince P Combes A Dormont D Luyt CE Spinal cord infarction during venoarterial-extracorporeal membrane oxygenation support J Artif Organs 2020 23 4 388 393 10.1007/s10047-020-01179-8 32474793
Le Guennec L, Shor N, Levy B, Lebreton G, Leprince P, Combes A, Dormont D, Luyt CE. Spinal cord infarction during venoarterial-extracorporeal membrane oxygenation support. J Artif Organs. 2020;23(4):388–93.32474793 10.1007/s10047-020-01179-8
11. Crow J Lindsley J Cho SM Wang J Lantry JH 3rd Kim BS Tahsili-Fahadan P Analgosedation in critically Ill adults receiving extracorporeal membrane oxygenation support ASAIO J 2022 68 12 1419 1427 10.1097/MAT.0000000000001758 35593878
Crow J, Lindsley J, Cho SM, Wang J, Lantry JH 3rd, Kim BS, Tahsili-Fahadan P. Analgosedation in critically Ill adults receiving extracorporeal membrane oxygenation support. ASAIO J. 2022;68(12):1419–27.35593878 10.1097/MAT.0000000000001758
12. Cho SM Ziai W Geocadin R Choi CW Whitman G Arterial-sided oxygenator clot and TCD emboli in VA-ECMO Ann Thorac Surg 2018 107 1 326 327 10.1016/j.athoracsur.2018.06.082 30189194
Cho SM, Ziai W, Geocadin R, Choi CW, Whitman G. Arterial-sided oxygenator clot and TCD emboli in VA-ECMO. Ann Thorac Surg. 2018;107(1):326–7.30189194 10.1016/j.athoracsur.2018.06.082
13. Cho S-M Geocadin RG Caturegli G Chan V White B Dodd-o J Kim BS Sussman M Choi CW Whitman G Understanding characteristics of acute brain injury in adult ECMO: an autopsy study Crit Care Med 2020 94 1650
Cho S-M, Geocadin RG, Caturegli G, Chan V, White B, Dodd-o J, Kim BS, Sussman M, Choi CW, Whitman G, et al. Understanding characteristics of acute brain injury in adult ECMO: an autopsy study. Crit Care Med. 2020;94:1650.
14. Mateen FJ Muralidharan R Shinohara RT Parisi JE Schears GJ Wijdicks EF Neurological injury in adults treated with extracorporeal membrane oxygenation Arch Neurol 2011 68 12 1543 1549 10.1001/archneurol.2011.209 21825216
Mateen FJ, Muralidharan R, Shinohara RT, Parisi JE, Schears GJ, Wijdicks EF. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68(12):1543–9.21825216 10.1001/archneurol.2011.209
15. Zhao D Shou BL Caturegli G Trends on near-infrared spectroscopy associated with acute brain injury in venoarterial extracorporeal membrane oxygenation ASAIO J 2023 69 12 1083 1089 10.1097/MAT.0000000000002032 37556554
Zhao D, Shou BL, Caturegli G, et al. Trends on near-infrared spectroscopy associated with acute brain injury in venoarterial extracorporeal membrane oxygenation. ASAIO J. 2023;69(12):1083–9. 10.1097/MAT.0000000000002032.37556554 10.1097/MAT.0000000000002032
16. Pozzebon S Blandino Ortiz A Franchi F Cerebral near-infrared spectroscopy in adult patients undergoing veno-arterial extracorporeal membrane oxygenation Neurocrit Care 2018 29 1 94 104 10.1007/s12028-018-0512-1 29560599
Pozzebon S, Blandino Ortiz A, Franchi F, et al. Cerebral near-infrared spectroscopy in adult patients undergoing veno-arterial extracorporeal membrane oxygenation. Neurocrit Care. 2018;29(1):94–104. 10.1007/s12028-018-0512-1.29560599 10.1007/s12028-018-0512-1
17. Bertini P Marabotti A Paternoster G Regional cerebral oxygen saturation to predict favorable outcome in extracorporeal cardiopulmonary resuscitation: a systematic review and meta-analysis J Cardiothorac Vasc Anesth 2023 37 7 1265 1272 10.1053/j.jvca.2023.01.007 36759264
Bertini P, Marabotti A, Paternoster G, et al. Regional cerebral oxygen saturation to predict favorable outcome in extracorporeal cardiopulmonary resuscitation: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2023;37(7):1265–72. 10.1053/j.jvca.2023.01.007.36759264 10.1053/j.jvca.2023.01.007
18. Joram N Beqiri E Pezzato S Continuous monitoring of cerebral autoregulation in children supported by extracorporeal membrane oxygenation: a pilot study Neurocrit Care 2021 34 3 935 945 10.1007/s12028-020-01111-1 33029743
Joram N, Beqiri E, Pezzato S, et al. Continuous monitoring of cerebral autoregulation in children supported by extracorporeal membrane oxygenation: a pilot study. Neurocrit Care. 2021;34(3):935–45. 10.1007/s12028-020-01111-1.33029743 10.1007/s12028-020-01111-1
19. Tian F Farhat A Morriss MC Cerebral hemodynamic profile in ischemic and hemorrhagic brain injury acquired during pediatric extracorporeal membrane oxygenation Pediatr Crit Care Med 2020 21 10 879 885 10.1097/PCC.0000000000002438 32569240
Tian F, Farhat A, Morriss MC, et al. Cerebral hemodynamic profile in ischemic and hemorrhagic brain injury acquired during pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2020;21(10):879–85. 10.1097/PCC.0000000000002438.32569240 10.1097/PCC.0000000000002438
20. Caturegli G Zhang LQ Mayasi Y Characterization of cerebral hemodynamics with TCD in patients undergoing VA-ECMO and VV-ECMO: a prospective observational study Neurocrit Care 2023 38 2 407 413 10.1007/s12028-022-01653-6 36510107
Caturegli G, Zhang LQ, Mayasi Y, et al. Characterization of cerebral hemodynamics with TCD in patients undergoing VA-ECMO and VV-ECMO: a prospective observational study. Neurocrit Care. 2023;38(2):407–13. 10.1007/s12028-022-01653-6.36510107 10.1007/s12028-022-01653-6
21. Kavi T Esch M Rinsky B Rosengart A Lahiri S Lyden PD Transcranial doppler changes in patients treated with extracorporeal membrane oxygenation J Stroke Cerebrovasc Dis 2016 25 12 2882 2885 10.1016/j.jstrokecerebrovasdis.2016.07.050 27576213
Kavi T, Esch M, Rinsky B, Rosengart A, Lahiri S, Lyden PD. Transcranial doppler changes in patients treated with extracorporeal membrane oxygenation. J Stroke Cerebrovasc Dis. 2016;25(12):2882–5. 10.1016/j.jstrokecerebrovasdis.2016.07.050.27576213 10.1016/j.jstrokecerebrovasdis.2016.07.050
22. Caturegli G Kapoor S Ponomarev V Transcranial Doppler microemboli and acute brain injury in extracorporeal membrane oxygenation: a prospective observational study JTCVS Tech 2022 15 111 122 10.1016/j.xjtc.2022.07.026 36276670
Caturegli G, Kapoor S, Ponomarev V, et al. Transcranial Doppler microemboli and acute brain injury in extracorporeal membrane oxygenation: a prospective observational study. JTCVS Tech. 2022;15:111–22. 10.1016/j.xjtc.2022.07.026.36276670 10.1016/j.xjtc.2022.07.026
23. Oddo M Taccone FS Petrosino M The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study Lancet Neurol 2023 22 10 925 933 10.1016/S1474-4422(23)00271-5 37652068
Oddo M, Taccone FS, Petrosino M, et al. The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study. Lancet Neurol. 2023;22(10):925–33. 10.1016/S1474-4422(23)00271-5.37652068 10.1016/S1474-4422(23)00271-5
24. Miroz JP Ben-Hamouda N Bernini A Neurological pupil index for early prognostication after venoarterial extracorporeal membrane oxygenation Chest 2020 157 5 1167 1174 10.1016/j.chest.2019.11.037 31870911
Miroz JP, Ben-Hamouda N, Bernini A, et al. Neurological pupil index for early prognostication after venoarterial extracorporeal membrane oxygenation. Chest. 2020;157(5):1167–74. 10.1016/j.chest.2019.11.037.31870911 10.1016/j.chest.2019.11.037
25. Magalhaes E Reuter J Wanono R Early EEG for prognostication under venoarterial extracorporeal membrane oxygenation Neurocrit Care 2020 33 3 688 694 10.1007/s12028-020-01066-3 32789602
Magalhaes E, Reuter J, Wanono R, et al. Early EEG for prognostication under venoarterial extracorporeal membrane oxygenation. Neurocrit Care. 2020;33(3):688–94. 10.1007/s12028-020-01066-3.32789602 10.1007/s12028-020-01066-3
26. Amorim E Firme MS Zheng WL High incidence of epileptiform activity in adults undergoing extracorporeal membrane oxygenation Clin Neurophysiol 2022 140 4 11 10.1016/j.clinph.2022.04.018 35691268
Amorim E, Firme MS, Zheng WL, et al. High incidence of epileptiform activity in adults undergoing extracorporeal membrane oxygenation. Clin Neurophysiol. 2022;140:4–11. 10.1016/j.clinph.2022.04.018.35691268 10.1016/j.clinph.2022.04.018
27. Sinnah F Dalloz MA Magalhaes E Early electroencephalography findings in cardiogenic shock patients treated by venoarterial extracorporeal membrane oxygenation Crit Care Med 2018 46 5 e389 e394 10.1097/CCM.0000000000003010 29389771
Sinnah F, Dalloz MA, Magalhaes E, et al. Early electroencephalography findings in cardiogenic shock patients treated by venoarterial extracorporeal membrane oxygenation. Crit Care Med. 2018;46(5):e389–94. 10.1097/CCM.0000000000003010.29389771 10.1097/CCM.0000000000003010
28. Peluso L Rechichi S Franchi F Electroencephalographic features in patients undergoing extracorporeal membrane oxygenation Crit Care 2020 24 1 629 10.1186/s13054-020-03353-z 33126887
Peluso L, Rechichi S, Franchi F, et al. Electroencephalographic features in patients undergoing extracorporeal membrane oxygenation. Crit Care. 2020;24(1):629. 10.1186/s13054-020-03353-z.33126887 10.1186/s13054-020-03353-z
29. Cho SM Choi CW Whitman G Neurophysiological findings and brain injury pattern in patients on ECMO Clin EEG Neurosci 2021 52 6 462 469 10.1177/1550059419892757 31823652
Cho SM, Choi CW, Whitman G, et al. Neurophysiological findings and brain injury pattern in patients on ECMO. Clin EEG Neurosci. 2021;52(6):462–9. 10.1177/1550059419892757.31823652 10.1177/1550059419892757
30. Ben-Hamouda N Ltaief Z Kirsch M Neuroprognostication under ecmo after cardiac arrest: Are classical tools still performant? Neurocrit Care 2022 37 1 293 301 10.1007/s12028-022-01516-0 35534658
Ben-Hamouda N, Ltaief Z, Kirsch M, et al. Neuroprognostication under ecmo after cardiac arrest: Are classical tools still performant? Neurocrit Care. 2022;37(1):293–301. 10.1007/s12028-022-01516-0.35534658 10.1007/s12028-022-01516-0
31. Kim YO Ko RE Chung CR Prognostic value of early intermittent electroencephalography in patients after extracorporeal cardiopulmonary resuscitation J Clin Med 2020 9 6 1745 10.3390/jcm9061745 32512910
Kim YO, Ko RE, Chung CR, et al. Prognostic value of early intermittent electroencephalography in patients after extracorporeal cardiopulmonary resuscitation. J Clin Med. 2020;9(6):1745. 10.3390/jcm9061745.32512910 10.3390/jcm9061745
32. Lidegran MK Mosskin M Ringertz HG Frenckner BP Linden VB Cranial CT for diagnosis of intracranial complications in adult and pediatric patients during ECMO: clinical benefits in diagnosis and treatment Acad Radiol 2007 14 1 62 71 10.1016/j.acra.2006.10.004 17178367
Lidegran MK, Mosskin M, Ringertz HG, Frenckner BP, Linden VB. Cranial CT for diagnosis of intracranial complications in adult and pediatric patients during ECMO: clinical benefits in diagnosis and treatment. Acad Radiol. 2007;14(1):62–71. 10.1016/j.acra.2006.10.004.17178367 10.1016/j.acra.2006.10.004
33. Cvetkovic M Chiarini G Belliato M International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe Perfusion 2023 38 2 245 260 10.1177/02676591211042563 34550013
Cvetkovic M, Chiarini G, Belliato M, et al. International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe. Perfusion. 2023;38(2):245–60. 10.1177/02676591211042563.34550013 10.1177/02676591211042563
34. Malfertheiner MV Koch A Fisser C Incidence of early intra-cranial bleeding and ischaemia in adult veno-arterial extracorporeal membrane oxygenation and extracorporeal cardiopulmonary resuscitation patients: a retrospective analysis of risk factors Perfusion 2020 35 8 17 10.1177/0267659120907438 32397881
Malfertheiner MV, Koch A, Fisser C, et al. Incidence of early intra-cranial bleeding and ischaemia in adult veno-arterial extracorporeal membrane oxygenation and extracorporeal cardiopulmonary resuscitation patients: a retrospective analysis of risk factors. Perfusion. 2020;35:8–17. 10.1177/0267659120907438.32397881 10.1177/0267659120907438
35. Lockie CJA Gillon SA Barrett NA Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage Crit Care Med 2017 45 10 1642 1649 10.1097/CCM.0000000000002579 28727576
Lockie CJA, Gillon SA, Barrett NA, et al. Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage. Crit Care Med. 2017;45(10):1642–9. 10.1097/CCM.0000000000002579.28727576 10.1097/CCM.0000000000002579
36. Zotzmann V Rilinger J Lang CN Early full-body computed tomography in patients after extracorporeal cardiopulmonary resuscitation (eCPR) Resuscitation 2020 146 149 154 10.1016/j.resuscitation.2019.11.024 31811881
Zotzmann V, Rilinger J, Lang CN, et al. Early full-body computed tomography in patients after extracorporeal cardiopulmonary resuscitation (eCPR). Resuscitation. 2020;146:149–54. 10.1016/j.resuscitation.2019.11.024.31811881 10.1016/j.resuscitation.2019.11.024
37. Prokupets R Kannapadi N Chang H Management of anticoagulation therapy in ECMO-associated ischemic stroke and intracranial hemorrhage Innovations (Phila). 2023 18 1 49 57 10.1177/15569845221141702 36628944
Prokupets R, Kannapadi N, Chang H, et al. Management of anticoagulation therapy in ECMO-associated ischemic stroke and intracranial hemorrhage. Innovations (Phila). 2023;18(1):49–57. 10.1177/15569845221141702.36628944 10.1177/15569845221141702
38. Cho SM Wilcox C Keller S Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience Crit Care 2022 26 1 119 10.1186/s13054-022-03990-6 35501837
Cho SM, Wilcox C, Keller S, et al. Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience. Crit Care. 2022;26(1):119. 10.1186/s13054-022-03990-6.35501837 10.1186/s13054-022-03990-6
39. Lorusso R Taccone FS Belliato M Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments Minerva Anestesiol 2017 83 10 1061 1074 10.23736/S0375-9393.17.11911-5 28643997
Lorusso R, Taccone FS, Belliato M, et al. Brain monitoring in adult and pediatric ECMO patients: the importance of early and late assessments. Minerva Anestesiol. 2017;83(10):1061–74. 10.23736/S0375-9393.17.11911-5.28643997 10.23736/S0375-9393.17.11911-5
40. Khanduja S Kim J Kang JK Hypoxic-ischemic brain injury in ecmo: pathophysiology, neuromonitoring, and therapeutic opportunities Cells 2023 12 11 1546 10.3390/cells12111546 37296666
Khanduja S, Kim J, Kang JK, et al. Hypoxic-ischemic brain injury in ecmo: pathophysiology, neuromonitoring, and therapeutic opportunities. Cells. 2023;12(11):1546. 10.3390/cells12111546.37296666 10.3390/cells12111546
41. de Jonge E Peelen L Keijzers PJ Joore H de Lange D van der Voort PH Bosman RJ de Waal RA Wesselink R de Keizer NF Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients Crit Care 2008 12 6 R156 10.1186/cc7150 19077208
de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156.19077208 10.1186/cc7150
42. Al-Kawaz MN Canner J Caturegli G Kannapadi N Balucani C Shelley L Kim BS Choi CW Geocadin RG Whitman G Duration of hyperoxia and neurologic outcomes in patients undergoing extracorporeal membrane oxygenation Crit Care Med 2021 49 10 e968 e977 10.1097/CCM.0000000000005069 33935164
Al-Kawaz MN, Canner J, Caturegli G, Kannapadi N, Balucani C, Shelley L, Kim BS, Choi CW, Geocadin RG, Whitman G, et al. Duration of hyperoxia and neurologic outcomes in patients undergoing extracorporeal membrane oxygenation. Crit Care Med. 2021;49(10):e968–77.33935164 10.1097/CCM.0000000000005069
43. Akbar AF Shou BL Feng CY Zhao DX Kim BS Whitman G Bush EL Cho SM Investigators H Lower oxygen tension and intracranial hemorrhage in veno-venous extracorporeal membrane oxygenation Lung 2023 201 3 315 320 10.1007/s00408-023-00618-6 37086285
Akbar AF, Shou BL, Feng CY, Zhao DX, Kim BS, Whitman G, Bush EL, Cho SM, Investigators H. Lower oxygen tension and intracranial hemorrhage in veno-venous extracorporeal membrane oxygenation. Lung. 2023;201(3):315–20.37086285 10.1007/s00408-023-00618-6
44. Cho SM Canner J Chiarini G Calligy K Caturegli G Rycus P Barbaro RP Tonna J Lorusso R Kilic A Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry Crit Care Med 2020 48 10 e897 e905 10.1097/CCM.0000000000004498 32931195
Cho SM, Canner J, Chiarini G, Calligy K, Caturegli G, Rycus P, Barbaro RP, Tonna J, Lorusso R, Kilic A, et al. Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry. Crit Care Med. 2020;48(10):e897–905.32931195 10.1097/CCM.0000000000004498
45. Harper AM Bell RA The effect of metabolic acidosis and alkalosis on the blood flow through the cerebral cortex J Neurol Neurosurg Psychiatry 1963 26 4 341 344 10.1136/jnnp.26.4.341 14043049
Harper AM, Bell RA. The effect of metabolic acidosis and alkalosis on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry. 1963;26(4):341–4.14043049 10.1136/jnnp.26.4.341
46. Dulla CG Dobelis P Pearson T Frenguelli BG Staley KJ Masino SA Adenosine and ATP link PCO2 to cortical excitability via pH Neuron 2005 48 6 1011 1023 10.1016/j.neuron.2005.11.009 16364904
Dulla CG, Dobelis P, Pearson T, Frenguelli BG, Staley KJ, Masino SA. Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron. 2005;48(6):1011–23.16364904 10.1016/j.neuron.2005.11.009
47. Meng L Gelb AW Regulation of cerebral autoregulation by carbon dioxide Anesthesiology 2015 122 1 196 205 10.1097/ALN.0000000000000506 25401418
Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology. 2015;122(1):196–205.25401418 10.1097/ALN.0000000000000506
48. Deng B Ying J Mu D Subtypes and mechanistic advances of extracorporeal membrane oxygenation-related acute brain injury Brain Sci 2023 13 8 1165 10.3390/brainsci13081165 37626521
Deng B, Ying J, Mu D. Subtypes and mechanistic advances of extracorporeal membrane oxygenation-related acute brain injury. Brain Sci. 2023;13(8):1165.37626521 10.3390/brainsci13081165
49. Cavayas YA Munshi L Del Sorbo L Fan E The early change in Pa Am J Respir Crit Care Med 2020 201 12 1525 1535 10.1164/rccm.202001-0023OC 32251606
Cavayas YA, Munshi L, Del Sorbo L, Fan E. The early change in Pa. Am J Respir Crit Care Med. 2020;201(12):1525–35.32251606 10.1164/rccm.202001-0023OC
50. Shou BL Ong CS Zhou AL Al-Kawaz MN Etchill E Giuliano K Dong J Bush E Kim BS Choi CW Arterial carbon dioxide and acute brain injury in venoarterial extracorporeal membrane oxygenation ASAIO J 2022 42 4 503 511
Shou BL, Ong CS, Zhou AL, Al-Kawaz MN, Etchill E, Giuliano K, Dong J, Bush E, Kim BS, Choi CW, et al. Arterial carbon dioxide and acute brain injury in venoarterial extracorporeal membrane oxygenation. ASAIO J. 2022;42(4):503–11.
51. van der Worp HB Sena ES Donnan GA Howells DW Macleod MR Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis Brain 2007 130 Pt 12 3063 3074 10.1093/brain/awm083 17478443
van der Worp HB, Sena ES, Donnan GA, Howells DW, Macleod MR. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain. 2007;130(Pt 12):3063–74.17478443 10.1093/brain/awm083
52. Huang M Shoskes A Migdady I Amin M Hasan L Price C Uchino K Choi CW Hernandez AV Cho SM Does targeted temperature management improve neurological outcome in extracorporeal cardiopulmonary resuscitation (ECPR)? J Intensive Care Med 2022 37 2 157 167 10.1177/08850666211018982 34114481
Huang M, Shoskes A, Migdady I, Amin M, Hasan L, Price C, Uchino K, Choi CW, Hernandez AV, Cho SM. Does targeted temperature management improve neurological outcome in extracorporeal cardiopulmonary resuscitation (ECPR)? J Intensive Care Med. 2022;37(2):157–67.34114481 10.1177/08850666211018982
53. Levy B Girerd N Amour J Besnier E Nesseler N Helms J Delmas C Sonneville R Guidon C Rozec B Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation: a randomized clinical trial JAMA 2022 327 5 442 453 10.1001/jama.2021.24776 35103766
Levy B, Girerd N, Amour J, Besnier E, Nesseler N, Helms J, Delmas C, Sonneville R, Guidon C, Rozec B, et al. Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation: a randomized clinical trial. JAMA. 2022;327(5):442–53.35103766 10.1001/jama.2021.24776
54. Powers WJ Rabinstein AA Ackerson T Adeoye OM Bambakidis NC Becker K Biller J Brown M Demaerschalk BM Hoh B Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association Stroke 2018 49 3 e46 e110 10.1161/STR.0000000000000158 29367334
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2018;49(3):e46–110.29367334 10.1161/STR.0000000000000158
55. Minhas JS Moullaali TJ Rinkel GJE Anderson CS Blood pressure management after intracerebral and subarachnoid hemorrhage: the knowns and known unknowns Stroke 2022 53 4 1065 1073 10.1161/STROKEAHA.121.036139 35255708
Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood pressure management after intracerebral and subarachnoid hemorrhage: the knowns and known unknowns. Stroke. 2022;53(4):1065–73.35255708 10.1161/STROKEAHA.121.036139
56. Kazmi SO Sivakumar S Karakitsos D Alharthy A Lazaridis C Cerebral pathophysiology in extracorporeal membrane oxygenation: pitfalls in daily clinical management Crit Care Res Pract 2018 2018 3237810 29744226
Kazmi SO, Sivakumar S, Karakitsos D, Alharthy A, Lazaridis C. Cerebral pathophysiology in extracorporeal membrane oxygenation: pitfalls in daily clinical management. Crit Care Res Pract. 2018;2018:3237810.29744226
57. Shou BL Wilcox C Florissi I Kalra A Caturegli G Zhang LQ Bush E Kim B Keller SP Whitman GJR Early low pulse pressure in VA-ECMO is associated with acute brain injury Neurocrit Care 2023 38 3 612 621 10.1007/s12028-022-01607-y 36167950
Shou BL, Wilcox C, Florissi I, Kalra A, Caturegli G, Zhang LQ, Bush E, Kim B, Keller SP, Whitman GJR, et al. Early low pulse pressure in VA-ECMO is associated with acute brain injury. Neurocrit Care. 2023;38(3):612–21.36167950 10.1007/s12028-022-01607-y
58. Lee SI Lim YS Park CH Choi WS Choi CH Importance of pulse pressure after extracorporeal cardiopulmonary resuscitation J Card Surg 2021 36 8 2743 2750 10.1111/jocs.15614 33993537
Lee SI, Lim YS, Park CH, Choi WS, Choi CH. Importance of pulse pressure after extracorporeal cardiopulmonary resuscitation. J Card Surg. 2021;36(8):2743–50.33993537 10.1111/jocs.15614
59. Risnes I Wagner K Nome T Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation Ann Thorac Surg 2006 81 4 1401 1406 10.1016/j.athoracsur.2005.10.008 16564280
Risnes I, Wagner K, Nome T, et al. Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation. Ann Thorac Surg. 2006;81(4):1401–6. 10.1016/j.athoracsur.2005.10.008.16564280 10.1016/j.athoracsur.2005.10.008
60. von Bahr V Kalzen H Hultman J Long-term cognitive outcome and brain imaging in adults after extracorporeal membrane oxygenation Crit Care Med 2018 46 5 e351 e358 10.1097/CCM.0000000000002992 29384779
von Bahr V, Kalzen H, Hultman J, et al. Long-term cognitive outcome and brain imaging in adults after extracorporeal membrane oxygenation. Crit Care Med. 2018;46(5):e351–8. 10.1097/CCM.0000000000002992.29384779 10.1097/CCM.0000000000002992
61. Ropper AH O'Rourke D Kennedy SK Head position, intracranial pressure, and compliance Neurology 1982 32 11 1288 1291 10.1212/WNL.32.11.1288 6890165
Ropper AH, O’Rourke D, Kennedy SK. Head position, intracranial pressure, and compliance. Neurology. 1982;32(11):1288–91.6890165 10.1212/WNL.32.11.1288
62. Blanco P Abdo-Cuza A Transcranial Doppler ultrasound in neurocritical care J Ultrasound 2018 21 1 1 16 10.1007/s40477-018-0282-9 29429015
Blanco P, Abdo-Cuza A. Transcranial Doppler ultrasound in neurocritical care. J Ultrasound. 2018;21(1):1–16.29429015 10.1007/s40477-018-0282-9
63. Miller C Armonda R Participants in the International Multi-disciplinary Consensus conference on Multimodality Monitoring of cerebral blood flow and ischemia in the critically ill Neurocrit Care 2014 21 2 1 26
Miller C, Armonda R. Participants in the International Multi-disciplinary Consensus conference on Multimodality Monitoring of cerebral blood flow and ischemia in the critically ill. Neurocrit Care. 2014;21(2):1–26.
64. Raha O Hall C Malik A D'Anna L Lobotesis K Kwan J Banerjee S Advances in mechanical thrombectomy for acute ischaemic stroke BMJ Med 2023 2 1 e000407 10.1136/bmjmed-2022-000407 37577026
Raha O, Hall C, Malik A, D’Anna L, Lobotesis K, Kwan J, Banerjee S. Advances in mechanical thrombectomy for acute ischaemic stroke. BMJ Med. 2023;2(1): e000407.37577026 10.1136/bmjmed-2022-000407
65. Friesenecker BE Peer R Rieder J Lirk P Knotzer H Hasibeder WR Mayr AJ Dunser MW Craniotomy during ECMO in a severely traumatized patient Acta Neurochir (Wien) 2005 147 9 993 996 10.1007/s00701-005-0568-5 16021388
Friesenecker BE, Peer R, Rieder J, Lirk P, Knotzer H, Hasibeder WR, Mayr AJ, Dunser MW. Craniotomy during ECMO in a severely traumatized patient. Acta Neurochir (Wien). 2005;147(9):993–6.16021388 10.1007/s00701-005-0568-5
66. Ryu KM Chang SW Heparin-free extracorporeal membrane oxygenation in a patient with severe pulmonary contusions and bronchial disruption Clin Exp Emerg Med 2018 5 3 204 207 10.15441/ceem.17.252 29706054
Ryu KM, Chang SW. Heparin-free extracorporeal membrane oxygenation in a patient with severe pulmonary contusions and bronchial disruption. Clin Exp Emerg Med. 2018;5(3):204–7.29706054 10.15441/ceem.17.252
67. Lamarche Y Chow B Bedard A Johal N Kaan A Humphries KH Cheung A Thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation Innovations (Phila) 2010 5 6 424 429 10.1177/155698451000500608 22437638
Lamarche Y, Chow B, Bedard A, Johal N, Kaan A, Humphries KH, Cheung A. Thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation. Innovations (Phila). 2010;5(6):424–9.22437638 10.1177/155698451000500608
68. Fina D Matteucci M Jiritano F Meani P Lo Coco V Kowalewski M Maessen J Guazzi M Ballotta A Ranucci M Lorusso R Extracorporeal membrane oxygenation without therapeutic anticoagulation in adults: a systematic review of the current literature Int J Artif Organs 2020 43 9 570 578 10.1177/0391398820904372 32037946
Fina D, Matteucci M, Jiritano F, Meani P, Lo Coco V, Kowalewski M, Maessen J, Guazzi M, Ballotta A, Ranucci M, Lorusso R. Extracorporeal membrane oxygenation without therapeutic anticoagulation in adults: a systematic review of the current literature. Int J Artif Organs. 2020;43(9):570–8.32037946 10.1177/0391398820904372
69. Fletcher-Sandersjoo A Thelin EP Bartek J Jr Elmi-Terander A Broman M Bellander BM Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): an observational cohort study PLoS ONE 2017 12 12 e0190365 10.1371/journal.pone.0190365 29267368
Fletcher-Sandersjoo A, Thelin EP, Bartek J Jr, Elmi-Terander A, Broman M, Bellander BM. Management of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation (ECMO): an observational cohort study. PLoS ONE. 2017;12(12): e0190365.29267368 10.1371/journal.pone.0190365
70. Mazzeffi M Kon Z Menaker J Johnson DM Parise O Gelsomino S Lorusso R Herr D Large dual-lumen extracorporeal membrane oxygenation cannulas are associated with more intracranial hemorrhage ASAIO J 2019 65 7 674 677 10.1097/MAT.0000000000000917 30398981
Mazzeffi M, Kon Z, Menaker J, Johnson DM, Parise O, Gelsomino S, Lorusso R, Herr D. Large dual-lumen extracorporeal membrane oxygenation cannulas are associated with more intracranial hemorrhage. ASAIO J. 2019;65(7):674–7.30398981 10.1097/MAT.0000000000000917
71. Idiculla PS Gurala D Palanisamy M Vijayakumar R Dhandapani S Nagarajan E Cerebral venous thrombosis: a comprehensive review Eur Neurol 2020 83 4 369 379 10.1159/000509802 32877892
Idiculla PS, Gurala D, Palanisamy M, Vijayakumar R, Dhandapani S, Nagarajan E. Cerebral venous thrombosis: a comprehensive review. Eur Neurol. 2020;83(4):369–79.32877892 10.1159/000509802
72. Saposnik G Barinagarrementeria F Brown RD Jr Bushnell CD Cucchiara B Cushman M deVeber G Ferro JM Tsai FY Stroke C American Heart Association Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 2011 42 4 1158 1192 10.1161/STR.0b013e31820a8364 21293023
Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY, Stroke C, American Heart Association, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–92.21293023 10.1161/STR.0b013e31820a8364
73. Einhaupl K Stam J Bousser MG De Bruijn SF Ferro JM Martinelli I Masuhr F European federation of neurological S: EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients Eur J Neurol 2010 17 10 1229 1235 10.1111/j.1468-1331.2010.03011.x 20402748
Einhaupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, Masuhr F. European federation of neurological S: EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17(10):1229–35.20402748 10.1111/j.1468-1331.2010.03011.x
74. Nolan JP Sandroni C Bottiger BW Cariou A Cronberg T Friberg H Genbrugge C Haywood K Lilja G Moulaert VRM European resuscitation council and european society of intensive care medicine guidelines 2021: post-resuscitation care Resuscitation 2021 161 220 269 10.1016/j.resuscitation.2021.02.012 33773827
Nolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, et al. European resuscitation council and european society of intensive care medicine guidelines 2021: post-resuscitation care. Resuscitation. 2021;161:220–69.33773827 10.1016/j.resuscitation.2021.02.012
75. Nutma S Ruijter BJ Beishuizen A Tromp SC Scholten E Horn J van den Bergh WM van Kranen-Mastenbroek VH Thomeer EC Moudrous W Myoclonus in comatose patients with electrographic status epilepticus after cardiac arrest: corresponding EEG patterns, effects of treatment and outcomes Resuscitation 2023 186 109745 10.1016/j.resuscitation.2023.109745 36822459
Nutma S, Ruijter BJ, Beishuizen A, Tromp SC, Scholten E, Horn J, van den Bergh WM, van Kranen-Mastenbroek VH, Thomeer EC, Moudrous W, et al. Myoclonus in comatose patients with electrographic status epilepticus after cardiac arrest: corresponding EEG patterns, effects of treatment and outcomes. Resuscitation. 2023;186: 109745.36822459 10.1016/j.resuscitation.2023.109745
76. Peluso L Oddo M Minini A Citerio G Horn J Di Bernardini E Rundgren M Cariou A Payen JF Storm C Neurological pupil index and its association with other prognostic tools after cardiac arrest: a post hoc analysis Resuscitation 2022 179 259 266 10.1016/j.resuscitation.2022.07.030 35914656
Peluso L, Oddo M, Minini A, Citerio G, Horn J, Di Bernardini E, Rundgren M, Cariou A, Payen JF, Storm C, et al. Neurological pupil index and its association with other prognostic tools after cardiac arrest: a post hoc analysis. Resuscitation. 2022;179:259–66.35914656 10.1016/j.resuscitation.2022.07.030
77. Elmer J Kurz MC Coppler PJ Steinberg A DeMasi S De-Arteaga M Simon N Zadorozhny VI Flickinger KL Callaway CW Time to awakening and self-fulfilling prophecies after cardiac arrest Crit Care Med 2023 51 4 503 512 10.1097/CCM.0000000000005790 36752628
Elmer J, Kurz MC, Coppler PJ, Steinberg A, DeMasi S, De-Arteaga M, Simon N, Zadorozhny VI, Flickinger KL, Callaway CW, et al. Time to awakening and self-fulfilling prophecies after cardiac arrest. Crit Care Med. 2023;51(4):503–12.36752628 10.1097/CCM.0000000000005790
78. Cho SM Khanduja S Kim J Kang JK Briscoe J Arlinghaus LR Dinh K Kim BS Sair HI Wandji AN Moreno E Torres G Gavito-Higuera J Choi HA Pitts J Gusdon AM Whitman GJ detection of acute brain injury in intensive care unit patients on ECMO support using ultra-low-field portable mri: a retrospective analysis compared to head CT Diagnostics (Basel) 2024 14 6 606 10.3390/diagnostics14060606 38535027
Cho SM, Khanduja S, Kim J, Kang JK, Briscoe J, Arlinghaus LR, Dinh K, Kim BS, Sair HI, Wandji AN, Moreno E, Torres G, Gavito-Higuera J, Choi HA, Pitts J, Gusdon AM, Whitman GJ. detection of acute brain injury in intensive care unit patients on ECMO support using ultra-low-field portable mri: a retrospective analysis compared to head CT. Diagnostics (Basel). 2024;14(6):606.38535027 10.3390/diagnostics14060606
79. Cho SM, Khanduja S, Wilcox C, Dinh K, Kim J, Kang JK, Chinedozi ID, Darby Z, Acton M, Rando H, Briscoe J, Bush E, Sair HI, Pitts J, Arlinghaus LR, Wandji AN, Moreno E, Torres G, Akkanti B, Gavito-Higuera J, Keller S, Choi HA, Kim BS, Gusdon A, Whitman GJ. Clinical use of bedside portable low-field brain magnetic resonance imaging in patients on ECMO: The results from multicenter SAFE MRI ECMO study. Res Sq [Preprint]. 2024
80. Rajajee V Muehlschlegel S Wartenberg KE Alexander SA Busl KM Chou SHY Creutzfeldt CJ Fontaine GV Fried H Hocker SE Guidelines for neuroprognostication in comatose adult survivors of cardiac arrest Neurocrit Care 2023 38 3 533 563 10.1007/s12028-023-01688-3 36949360
Rajajee V, Muehlschlegel S, Wartenberg KE, Alexander SA, Busl KM, Chou SHY, Creutzfeldt CJ, Fontaine GV, Fried H, Hocker SE, et al. Guidelines for neuroprognostication in comatose adult survivors of cardiac arrest. Neurocrit Care. 2023;38(3):533–63.36949360 10.1007/s12028-023-01688-3
81. Sandroni C D'Arrigo S Cacciola S Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review Intensive Care Med 2022 48 4 389 413 10.1007/s00134-022-06618-z 35244745
Sandroni C, D’Arrigo S, Cacciola S, et al. Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review. Intensive Care Med. 2022;48(4):389–413. 10.1007/s00134-022-06618-z.35244745 10.1007/s00134-022-06618-z
82. Moynihan KM Dorste A Siegel BD Rabinowitz EJ McReynolds A October TW Decision-making, ethics, and end-of-life care in pediatric extracorporeal membrane oxygenation: a comprehensive narrative review Pediatr Crit Care Med 2021 22 9 806 812 10.1097/PCC.0000000000002766 33989251
Moynihan KM, Dorste A, Siegel BD, Rabinowitz EJ, McReynolds A, October TW. Decision-making, ethics, and end-of-life care in pediatric extracorporeal membrane oxygenation: a comprehensive narrative review. Pediatr Crit Care Med. 2021;22(9):806–12. 10.1097/PCC.0000000000002766.33989251 10.1097/PCC.0000000000002766
83. Onrust M Lansink-Hartgring AO van der Meulen I Luttik ML de Jong J Dieperink W Coping strategies, anxiety and depressive symptoms in family members of patients treated with extracorporeal membrane oxygenation: a prospective cohort study Heart Lung Mar 2022 52 146 151 10.1016/j.hrtlng.2022.01.002
Onrust M, Lansink-Hartgring AO, van der Meulen I, Luttik ML, de Jong J, Dieperink W. Coping strategies, anxiety and depressive symptoms in family members of patients treated with extracorporeal membrane oxygenation: a prospective cohort study. Heart Lung Mar. 2022;52:146–51. 10.1016/j.hrtlng.2022.01.002.10.1016/j.hrtlng.2022.01.002
84. Wirpsa MJ Carabini LM Neely KJ Kroll C Wocial LD Mitigating ethical conflict and moral distress in the care of patients on ECMO: impact of an automatic ethics consultation protocol J Med Ethics 2021 10.1136/medethics-2020-106881 33441301
Wirpsa MJ, Carabini LM, Neely KJ, Kroll C, Wocial LD. Mitigating ethical conflict and moral distress in the care of patients on ECMO: impact of an automatic ethics consultation protocol. J Med Ethics. 2021. 10.1136/medethics-2020-106881.33441301 10.1136/medethics-2020-106881
85. Petermichl W Philipp A Hiller KA Foltan M Floerchinger B Graf B Lunz D Reliability of prognostic biomarkers after prehospital extracorporeal cardiopulmonary resuscitation with target temperature management Scand J Trauma Resusc Emerg Med 2021 29 1 147 10.1186/s13049-021-00961-8 34627354
Petermichl W, Philipp A, Hiller KA, Foltan M, Floerchinger B, Graf B, Lunz D. Reliability of prognostic biomarkers after prehospital extracorporeal cardiopulmonary resuscitation with target temperature management. Scand J Trauma Resusc Emerg Med. 2021;29(1):147.34627354 10.1186/s13049-021-00961-8
86. Gregorio T Pipa S Cavaleiro P Atanasio G Albuquerque I Castro Chaves P Azevedo L Original intracerebral hemorrhage score for the prediction of short-term mortality in cerebral hemorrhage: systematic review and meta-analysis Crit Care Med 2019 47 6 857 864 10.1097/CCM.0000000000003744 30889025
Gregorio T, Pipa S, Cavaleiro P, Atanasio G, Albuquerque I, Castro Chaves P, Azevedo L. Original intracerebral hemorrhage score for the prediction of short-term mortality in cerebral hemorrhage: systematic review and meta-analysis. Crit Care Med. 2019;47(6):857–64.30889025 10.1097/CCM.0000000000003744
87. Cho SM Canner J Caturegli G Choi CW Etchill E Giuliano K Chiarini G Calligy K Rycus P Lorusso R Risk factors of ischemic and hemorrhagic strokes during venovenous extracorporeal membrane oxygenation: analysis of data from the extracorporeal life support organization registry Crit Care Med 2021 49 1 91 101 10.1097/CCM.0000000000004707 33148951
Cho SM, Canner J, Caturegli G, Choi CW, Etchill E, Giuliano K, Chiarini G, Calligy K, Rycus P, Lorusso R, et al. Risk factors of ischemic and hemorrhagic strokes during venovenous extracorporeal membrane oxygenation: analysis of data from the extracorporeal life support organization registry. Crit Care Med. 2021;49(1):91–101.33148951 10.1097/CCM.0000000000004707
88. Hwang J Kalra A Shou BL Whitman G Wilcox C Brodie D Zaaqoq AM Lorusso R Uchino K Cho SM Epidemiology of ischemic stroke and hemorrhagic stroke in venoarterial extracorporeal membrane oxygenation Crit Care 2023 27 1 433 10.1186/s13054-023-04707-z 37946237
Hwang J, Kalra A, Shou BL, Whitman G, Wilcox C, Brodie D, Zaaqoq AM, Lorusso R, Uchino K, Cho SM. Epidemiology of ischemic stroke and hemorrhagic stroke in venoarterial extracorporeal membrane oxygenation. Crit Care. 2023;27(1):433.37946237 10.1186/s13054-023-04707-z
89. Lie SA Hwang NC Challenges of brain death and apnea testing in adult patients on extracorporeal corporeal membrane oxygenation-a review J Cardiothorac Vasc Anesth 2019 33 8 2266 2272 10.1053/j.jvca.2019.01.042 30765209
Lie SA, Hwang NC. Challenges of brain death and apnea testing in adult patients on extracorporeal corporeal membrane oxygenation-a review. J Cardiothorac Vasc Anesth. 2019;33(8):2266–72.30765209 10.1053/j.jvca.2019.01.042
90. Machado DS Garros D Montuno L Avery LK Kittelson S Peek G Moynihan KM Finishing well: compassionate extracorporeal membrane oxygenation discontinuation J Pain Symptom Manage 2022 63 5 e553 e562 10.1016/j.jpainsymman.2021.11.010 35031504
Machado DS, Garros D, Montuno L, Avery LK, Kittelson S, Peek G, Moynihan KM. Finishing well: compassionate extracorporeal membrane oxygenation discontinuation. J Pain Symptom Manage. 2022;63(5):e553–62.35031504 10.1016/j.jpainsymman.2021.11.010
91. Kalra A Kang JK Khanduja S Menta AK Ahmad SA Liu O Rodriguez E Spann M Hernandez AV Brodie D Long-term neuropsychiatric, neurocognitive, and functional outcomes of patients receiving ECMO Neurology 2024 102 3 e208081 10.1212/WNL.0000000000208081 38181313
Kalra A, Kang JK, Khanduja S, Menta AK, Ahmad SA, Liu O, Rodriguez E, Spann M, Hernandez AV, Brodie D, et al. Long-term neuropsychiatric, neurocognitive, and functional outcomes of patients receiving ECMO. Neurology. 2024;102(3): e208081.38181313 10.1212/WNL.0000000000208081
92. Risnes I Heldal A Wagner K Psychiatric outcome after severe cardio-respiratory failure treated with extracorporeal membrane oxygenation: a case-series Psychosomatics 2013 54 5 418 427 10.1016/j.psym.2013.02.008 23756125
Risnes I, Heldal A, Wagner K, et al. Psychiatric outcome after severe cardio-respiratory failure treated with extracorporeal membrane oxygenation: a case-series. Psychosomatics. 2013;54(5):418–27. 10.1016/j.psym.2013.02.008.23756125 10.1016/j.psym.2013.02.008
93. Janssen MF Bonsel GJ Luo N Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries Pharmacoeconomics 2018 36 6 675 697 10.1007/s40273-018-0623-8 29470821
Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–97. 10.1007/s40273-018-0623-8.29470821 10.1007/s40273-018-0623-8
